Abciximab vs thrombectomy for reperfusion in myocardial infarction.
JAMA The Journal of the American Medical Association (impact factor: 30.03). 08/2012; 308(6):565-6; author reply 566-7. DOI:10.1001/jama.2012.8155 pp.565-6; author reply 566-7
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.